Prostate Cancer
Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract
February 6, 2012
The Epigenetic promise for prostate cancer diagnosis - Abstract
February 6, 2012
Study on the autophagy of prostate cancer PC-3 cells induced by oridonin - Abstract
February 6, 2012
Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3 - Abstract
February 3, 2012
Epigenetics in prostate cancer - Abstract
February 3, 2012
Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence - Abstract
February 3, 2012
Bone scan index: A quantitative treatment response biomarker for castration-resistant metastatic prostate cancer - Abstract
February 3, 2012
An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips - Abstract
February 3, 2012
A study of segment weight optimization with the CMS XiO step-and-shoot IMRT technique for prostate cancer - Abstract
February 3, 2012
Quality of life issues in men undergoing androgen deprivation therapy: A review - Abstract
February 3, 2012
Impact of androgen deprivation therapy on sexual function - Abstract
February 3, 2012
Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer - Abstract
February 3, 2012
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study - Abstract
February 3, 2012
Active surveillance in prostate cancer - Abstract
February 3, 2012